Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months

Transplant Proc. 1993 Feb;25(1 Pt 2):1535.
No abstract available

MeSH terms

  • Actuarial Analysis
  • Adult
  • Dobutamine / therapeutic use
  • Dopamine / therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Survival / drug effects
  • Graft Survival / physiology*
  • Heart Transplantation / physiology*
  • Hemodynamics / drug effects
  • Hemodynamics / physiology*
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Retrospective Studies
  • Survival Analysis
  • Thyroxine / therapeutic use*
  • Time Factors
  • Tissue Donors

Substances

  • Dobutamine
  • Thyroxine
  • Dopamine